PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancer

Zhou, HQ; Liu, JQ; Zhang, YX; Huang, Y; Shen, JY; Yang, YP; Fang, WF; Zhang, L

Fang, WF; Zhang, L (corresponding author), Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, Guangzhou, Peoples R China.; Fang, WF; Zhang, L (corresponding author), State Key Lab Oncol South China, Guangzhou, Peoples R China.; Fang, WF; Zhang, L (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China.

NPJ PRECISION ONCOLOGY, 2020; 4 (1):

Abstract

Polybromo-1 (PBRM1) gene is a promising biomarker for immunotherapy in clear cell renal cell carcinoma. But to our knowledge, the frequency and clinic......

Full Text Link